Surgical correction of rhinophyma: Comparison of two methods in a 15-year-long experience

Lazzeri, Davide; Larcher, Lorenz; Huemer, Georg M.; Riml, Stefan; Grassetti, Luca; Pantaloni, Marcello; Li, Qingfeng; Zhang, Yi Xin; Spinelli, Giuseppe; Agostini, Tommaso

doi:10.1016/j.jcms.2012.11.009

Cited by 28 publications

(35 citation statements)

References 31 publications

Supporting

Mentioning

Contrasting

Unclassified

Order By: Relevance

“…Most of the reports are not powered to generate generalizable conclusions, except perhaps two retrospective reviews of CO 2 laser . There are a handful of reports which retrospectively compare different modalities, including scalpel excision versus CO 2 laser and a split‐face study of laser versus electrosurgery . The results of these studies show comparable efficacy and side effect profile between the different treatments.…”

Section: Resultsmentioning

confidence: 99%

“…One study of 23 patients comparing blade excision to CO 2 laser found comparable results for many measured outcomes, except for increased intraoperative and postoperative bleeding with blade resection . Another study reviewed the long‐term complications of 65 patients treated with either excision or CO 2 laser and found both methods to be equally reliable with similar outcomes, though scalpel was recommended due to easy handling and low cost …”

Section: Treatmentmentioning

confidence: 99%

See 1 more Smart Citation

Procedural management of rhinophyma: A comprehensive review

Krausz

Goldberg

Ciocon

et al. 2018

J of Cosmetic Dermatology

View full text Add to dashboard Cite

There is no accepted gold standard for management of rhinophyma, and each modality succeeds in maintaining hemostasis, reducing scarring and achieving satisfactory cosmesis to different degrees. There is a conflicting data on the theoretical risk of recurrence with partial excision due to incomplete removal of tissue. Further studies evaluating this risk and alternate methods of prevention are required.

show abstract

Section: Resultsmentioning

confidence: 99%

Section: Treatmentmentioning

confidence: 99%

Procedural management of rhinophyma: A comprehensive review

Krausz

Goldberg

Ciocon

et al. 2018

J of Cosmetic Dermatology

View full text Add to dashboard Cite

show abstract

“…[120][121][122][123][124][125][126][127][128][129][130][131][132][133][134][135][136][137][138][139] All may be cosmetically limited due to excessive intraoperative bleeding obstructing visualization and causing imprecise tissue removal, along with the risk of scarring. Technological enhancements such as scanned and "superpulsed" systems emit shorter pulses with high power, reducing common adverse effects such as scarring and dyspigmentation.…”

Section: Co 2 Laser and Erbium:yttrium-aluminum-garnet Lasermentioning

confidence: 99%

“…The efficacy, safety, and cost-effectiveness of both agents are well demonstrated in a number of well controlled randomized studies. 26 A few Brimotidine tartrate gel 0.5% [22][23][24] Azelaic acid 15% Pimecrolimus 1% cream [31][32][33] Pimecrolimus 1% cream [31][32][33] Permethrin 5% cream [34][35][36]38 Permethrin 5% cream [34][35][36]38 Oral Surgical (blade and radio) excision 121,136 Other natural Ingredients (botnicals and anti-inflammatories) 43 KTP laser [113][114][115][116][117] Cryosurgery Nd:YAG laser 125 Dermabrasion OnabotulinumtoxinA 151,152 Abbreviations: BP, benzoyl peroxide; ETR, erythematotelangiectatic rosacea; PPR, papulopustular rosacea; Nd:YAG, neodymium:yttrium-aluminum-garnet laser; Er:YAG, erbium:yttrium-aluminum-garnet; PDL, pulsed dye laser; IPL, intense pulsed light; KTP, potassium titanyl phosphate; FDA, US Food and Drug Administration. …”

mentioning

confidence: 99%

Update on the Management of Rosacea

Weinkle

Doktor

Emer

2015

Plastic Surgical Nursing

View full text Add to dashboard Cite

Abstract:Refining diagnostic criteria has identified key characteristics differentiating rosacea, a chronic skin disorder, from other common cutaneous inflammatory conditions. The current classification system developed by the National Rosacea Society Expert Committee consists of erythematotelangiectatic, papulopustular, phymatous, and ocular subtypes. Each subtype stands as a unique entity among a spectrum, with characteristic symptoms and physical findings, along with an intricate pathophysiology. The main treatment modalities for rosacea include topical, systemic, laser, and light therapies. Topical brimonidine tartrate gel and calcineurin inhibitors are at the forefront of topical therapies, alone or in combination with traditional therapies such as topical metronidazole or azelaic acid and oral tetracyclines or isotretinoin. Vascular laser and intense pulsed light therapies are beneficial for the erythema and telangiectasia, as well as the symptoms (itching, burning, pain, stinging, swelling) of rosacea. Injectable botulinum toxin, topical ivermectin, and microsecond long-pulsed neodymium-yttrium aluminum garnet laser are emerging therapies that may prove to be extremely beneficial in the future. Once a debilitating disorder, rosacea has become a well known and manageable entity in the setting of numerous emerging therapeutic options. Herein, we describe the treatments currently available and give our opinions regarding emerging and combination therapies.

show abstract

“…Die Konturierung der Nase mittels Skalpell, hochtouriger Fräse oder CO 2 -Laser Therapie ist die Therapie der Wahl. Die unterschiedlichen Therapieverfahren liefern ähnliche Ergebnisse[ 15 ] .Abb. 11 Etagen nach a Sebileau und b Öhngren-Ebene [ 1 ] .Durch die Einnahme von systemisch oder topisch wirksamen Substanzen kann es ebenfalls zu einer Nasenatmungsbehinderung kommen, was als Rhinitis medicamentosa defi niert ist.…”

unclassified